PRP reduces retear rate post arthroscopic rotator cuff repair, but is not cost-effective .
This report has been verified
by one or more authors of the
original publication.
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Platelet-Rich Plasma Reduces Retear Rates After Arthroscopic Repair of Small- and Medium-Sized Rotator Cuff Tears but Is Not Cost-Effective
Am J Sports Med. 2015 Dec;43(12):3071-6.13 randomized controlled trials investigating the effects of platelet-rich plasma (PRP) in reducing re-tear rates post arthroscopic repair of rotator cuff tears were included in this analysis. The study was completed in order to determine if PRP was able to reduce re-tear rates in a cost-effective manner. While findings indicated that PRP reduced the amount of re-tears in small to medium sized tears, this was not true for massive or a combination of all tear sizes. Additionally, the intervention was not found to be cost-effective.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
